چاپ        ارسال به دوست

HOT Papers In Coronavirus


2019 Novel coronavirus infection and gastrointestinal tract 1
2019 Novel Coronavirus—Important Information 2
2019_nCoVRapid classification of betacoronaviruses and identification of traditional 3
2019-nCoV epidemic what about pregnancies 4
2019-nCoV in context lessons learned 5
2019-novel Coronavirus severe adult respiratory distress 6
2019-novel-coronavirus__2019-nCoV__outbrea_2020_Journal-of-Global-Antimicrob 7
2019-novel-coronavirus-disease__COVID-19__in-T_2020_Journal-of-Microbiology- 8
A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery  9
A conceptual model for the coronavirus disease 2019 (COVID-19) 10
A conceptual model for the outbreak of Coronavirus disease 2019 (COVID-19) in Wuhan, China with individual reactio-OCM_K8DT 11
A distinct name is needed for the new coronavirus 12
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmissio-BXUMJ4IU 13
A Genomic Perspective on the Origin 14
A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan 15
A mild type of childhood Covid-19 - A case report 16
A new pandemic out of China the Wuhan 2019-nCoV coronavirus 17
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome 18
A Novel Coronavirus Emerging in China Key Questions for Impact Assessment 19
A Novel Coronavirus from Patients with 20
A novel coronavirus outbreak of global health concern 21
A Novel Coronavirus(COVID-19) Outbreak A Call for Action 22
A novel presentation of COVID-19 via community acquired infection 23
A pneumonia outbreak associated with a new coronavirus of probable bat origin 24
A potential role for integrins in host cell entry by SARS-CoV-2 25
A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19 The 26
A risk-based approach is best for decision making on holding mass gathering events 27
A segregated-team model to maintain cancer care during the COVID-19 outbreak at 28
A Sequence Homology and Bioinformatic Approach 29
A special case of COVID-19 with long duration of viral shedding for 49 days  30
A strategy to prevent future epidemics similar to the 2019-nCoV outbreak 31
A-case-of-COVID-19-and-pneumonia-returning-from-M_2020_Journal-of-Microbiolo 32
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) 33
Actualización de la situaciónepidemiológica de la infección porSARS-CoV-2 en Espa˜na. 34
ACUTE KIDNEY INJURY ASSOCIATED WITH 35
Adaptations de la prise en charge des patients en Nutrition Artificielle à Domicile au cours 36
Advance of promising target sagainst Q1 37
Advice on Standardized Diagnosis and Treatment for Spinal Diseases during the Coronavirus Disease 2019 Pandemic 38
Aetiology of lower respiratory tract infection in adults in primary care a prospective study in 11 European countries 39
Africa prepares for coronavirus 40
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome C-9AO8OJFO 41
Aminoquinolines against coronavirus disease 2019 (COVID-19) 42
An update on the 2019-nCoV outbreak 43
An updated estimation of the risk of transmission of the novel 44
Analysis and forecast of COVID-19 spreading in China, Italy and France 45
ANALYSIS Nearly every persondying from the coronavirus likely has these three things in common 46
Analysis of angiotensin-converting enzyme 2 (ACE2) from 47
Analysis of preferred codon usage in the coronavirus N genes and their 48
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by 49
And now for something completely different from 50
Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Synd-63KLPUJD 51
Anesthetic-Management-of-Patients-with-COVID-_2020_Journal-of-Cardiothoracic 52
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor molecular mechanisms and potential therapeutic target 53
Another coronavirus, another epidemic, another warning 54
Antigenic variation among recent Japanese isolates of bovine 55
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 56
Antipsoriatic treatments covid 19 57
Application of the ARIMA model on the COVID- 58
Applying lessons from SARS to a newly identifi ed coronavirus 59
Approaches to the management of patients in oral and maxillofacial surgery during 60
Arbidol combined with LPVr versus LPVr alone against Corona Virus Disease 2019 A retrospective cohort study 61
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection 62
A-review-of-the-2019-Novel-Coronavirus__COVI_2020_International-Journal-of-A 63
Arguments in favour of remdesivir for treating SARS-CoV-2 infections 64
Arthralgia as an initial presentation of COVID‑19- observation 65
Assessment of the SARS-CoV-2 basic 66
Association between ambient temperature and COVID-19 67
Assurer les soins aux patients souffrant de troubles psychiques en 68
Asymptomatic novel coronavirus pneumonia patient outside Wuhan 69
Asymptomatic-carrier-state__acute-respiratory-disease-_2020_Journal-of-Micro 70
Asymptomatic-coronavirus-infection__MERS-CoV-a_2020_Travel-Medicine-and-Infe 71
A-systematic-review-on-the-efficacy-and-safety-of-chloro_2020_Journal-of-Cri 72
b68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit  73
Baricitinib for COVID-19- a suitable treatment 74
Base protocol for real time active random surveillance of 75
Breakthrough, Chloroquine phosphate has shown apparent 76
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses 77
Building resilience against biological hazards and pandemics COVID-19 and 78
C0031_Specialty-guide_LD-and-coronavirus-v1_-24-March (1) 79
C0032-Maintenance-of-TB-services_26-March-FINAL (1) 80
C033-Specialty-guide_-Stroke-and-coronavirus-v1-24March_ (1) 81
C0063-Specialty-guide-_Respiratory-and-Coronavirus-_v1_26-March (1) 82
C0081-Speciality-guide-Palliative-care-and-coronavirus (1) 83
C0086_Specialty-guide-_Fragility-Fractures-and-Coronavirus-v1-26-March (1) 84
C0086_Specialty-guide_-Paediatric-critical-care-v1-26-March (1) 85
C0087-specialty-guide-critical-care-standard-operating-procedure-and-coronavirus-v1-28-march 86
C0099-specialty-guide-immunoglobulin-coronavirus-v1-31-march (1) 87
Can Bioactive Lipids Inactivate Coronavirus (COVID-19) 88
Can we contain the COVID-19 outbreak with the same measures as for SARS 89
Canada needs to rapidly escalate public health interventions for its COVID-19 90
Cancer patients in SARS-CoV-2 infection a nationwide 91
Canwe contain the COVID-19 outbreak with the same 92
Cardiac troponin I in patients with coronavirus 93
Cardiovascular disease and COVID-19 94
Cardiovascular-Considerations-for-Patients__Health-Ca_2020_Journal-of-the-Am 95
Caring for persons in detention suffering with mental illness during the 96
CARTA CIENTÍFICAPrimer caso de infección neonatalpor SARS-CoV-2 97
Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Develop-9IS26O1D 98
Case of the Index Patient Who Caused 99
Caution and clarity required in the use of chloroquine for COVID-19 100
CDC Director Says 1 In 4 May Have No Coronavirus Symptoms _ Shots - Health News  101
CD-sACE2 inclusion compound An effective treatment for corona virus disease 2019  COVID 102
Challenges and countermeasures for organ 103
Challenges of coronavirus disease 2019 104
Challenges-of-SARS-CoV-2-and-lessons-learnt-from-SARS_2020_Journal-of-Clinic 105
Characteristics of and Important Lessons From 106
Characteristics of COVID-19 infection in Beijing 107
Characterization of novel monoclonal antibodies against MERS- 108
Chest CT for Non-Radiologists- A Practical Guide-2018 109
Chest CT for Typical 2019-nCoV Pneumonia Relationship to Negative RT-PCR  110
China coronavirus cases surge as official admits 111
China coronavirus Hong Kong health staff strike to 112
China coronavirus mild but infectious cases may make 113
China coronavirus partial border closures into Hong 114
China coronavirus should be on “everybody’s agenda,” 115
China coronavirus what do we know so far 116
China coronavirus WHO declares international 117
China empowers Internet hospital to fight against COVID-19 118
Chinese experts’ consensus on the Internet of Things-aided diagnosis and 119
Chinese Health Care Workers and COVID-19 For Whom the Bell Tolls 120
Chinese premier rallies medics in coronavirus fight 121
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 122
Chloroquine and hydroxychloroquine as available weapons to fight 123
Chloroquine-and-hydroxychloroquine-in-the-treatment-of-_2020_Diabetes__-Meta 124
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID‑19) infection 125
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 126
CIENTÍFICAPrimer caso de infección neonatalpor SARS-CoV-2 en Espa˜na 127
CLEARED_Specialty-guide_-NIV-respiratory-support-and-coronavirus-v2-26-March-003 (1) 128
Clinical and CT features in pediatric patients with COVID-19 infection, Different points from adults 129
Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19) 130
Clinical and CT imaging features of the COVID-19 pneumonia Focus 131
Clinical and epidemiological features of 36 children with 132
Clinical and High-Resolution CT Features of the COVID-19 Infection, Comparison of the Initial and Follow-up Changes 133
Clinical and virological data of the first cases of COVID-19 134
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19)A multi-center-R2_O8L7J 135
Clinical characteristics and intrauterine vertical transmission 136
Clinical characteristics and therapeutic procedure for four cases 137
Clinical Characteristics of 138 Hospitalized Patients 138
Clinical Characteristics of Coronavirus 139
Clinical characteristics of COVID-19-infected cancer patients A retrospective case 140
Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province A Multicenter Descriptive Study  141
Clinical characteristics of laboratory confirmed positive cases of SARS-CoV- 142
clinical characteristics of medical staff in covid 19 143
Clinical characteristics of novel coronavirus 144
Clinical considerations for patients with diabetes in times of COVID-19 145
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China a single-centere-R6XSVQPJ 146
Clinical course and risk factors for mortality of adult 147
Clinical evidence does not support corticosteroid treatment 148
Clinical features and obstetric and neonatal outcomes 149
Clinical features and short-term outcomes 150
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus -AOEO83FO 151
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection 152
Clinical features of COVID-19 in elderly patients A comparison with young and middle-aged patients 153
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China 154
Clinical findings in a group of patients infected with the 2019 155
Clinical guide for the management of major trauma patients during the coronavirus pandemic   156
Clinical Overview_Coronavirus  novel coronavirus (COVID-19) 157
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China 158
Clinical progression of patients with COVID-19 in Shanghai, China 159
Clinical Study of Mesenchymal Stem Cell Treatment for Acute 160
Clinical trial analysis of 2019-nCoV therapy 161
Clinical, laboratory and imaging features of COVID-19 A systematic review 162
Clinical-and-computed-tomographic-imaging-features-of-novel_2020_Journal-of- 163
Clinical-characteristics-of-severe-acute-respiratory-syndr_2020_Journal-of-I 164
Clinical-features-of-cases-and-a-cluster-of-Coronaviru_2020_Travel-Medicine- 165
clinical-guide-for-staff-supporting-patients-with-a-learning-disability-autism-or-both-easy-read 166
clinical-guide-rheumatology-patients-v1-19-march-2020-updated (1) 167
clinical-management-of-persons-admitted-to-hospita-v1-19-march-2020 168
CO0043_Specialty-guide-and-coronavirus_-MSK-corcosteroid_-v1-25March (1) 169
Combination of RT-qPCR Tes t ing and Clinical Features For 170
Commentary Of chloroquine and COVID-19 171
Comments on P¨ reliminary estimation of the basic reproduction number of novel Coronavirus 172
Community pharmacist in public health emergencies Quick to action 173
Community pharmacists and communication in the time of COVID-19 174
Comparison of different samples for 2019 novel coronavirus 175
Comparison of Hospitalized Patients with Acute Respiratory Distress Syndrome 176
Comparison-of-clinical-characteristics-of-coronavirus-di_2020_Travel-Medicin 177
Composition-of-human-specific-slow-codons-and-slow-di-co_2020_Journal-of-Mic 178
Computers-and-viral-diseases__Preliminary-bioinformatics-stud_2020_Computers 179
Considerations in performing endoscopy during the COVID-19 pandemic 180
Contentious issues and evolving concepts in the clinical presentation 181
Continuous evolution of avian infectious bronchitis virus resulting in different variants co-circulating in southern China 182
Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 183
Corona Virus Disease 2019, a growing threat to children 184
Corona Virus International Public Health Emergencies Implications for Radiology Management 185
corona virus 186
Coronavirus (COVID-19) Outbreak What the Department of Radiology Should Know 187
Coronavirus 2019-nCoV Is the genie already out of the bottle 188
Coronavirus can infect cats — dogs, not so much 189
Coronavirus Disease (COVID-19) Spectrum of CT Findings and Temporal Progression of the Disease 190
Coronavirus disease 2019 (COVID-19)- facts and controversies 191
Coronavirus Disease 2019 (COVID-19) Pneumonia 192
Coronavirus Disease 2019 (COVID-19), A Perspective from China 193
Coronavirus disease 2019 (COVID-19) 194
Coronavirus Disease 2019 and Influenza 195
Coronavirus Disease COVID-19, A New Threat to Public Health 196
Coronavirus doctor who faced backlash from police 197
Coronavirus does spread through the air and lingers in rooms long after patients have left 198
Coronavirus global stocks of protective gear are 199
Coronavirus in mother and baby 200
Coronavirus infections reported by ProMED, February 2000–January 2020 201
Coronavirus latest pandemic could have killed 40 million without any action  202
Coronavirus masks advice could change after new evidence emerges 203
Coronavirus online GP bookings should be stopped 204
Coronavirus- Potential vaccine generates enough antibodies to fight off virus, first peer-reviewed study suggests 205
Coronavirus- Scientists in Australia begin testing two potential vaccines 206
Coronavirus shows how UK must act quickly before 207
Coronavirus UK screens direct flights from Wuhan 208
Coronavirus-2019-nCoV__A-brief-perspective-from-the-f_2020_Journal-of-Infect 209
Coronavirus-Disease-2019__Coronaviruses-and-Blo_2020_Transfusion-Medicine-Re 210
Coronavirus-Disease-2019__COVID-19__and-Pregna_2020_American-Journal-of-Obst 211
Coronavirus-disease-2019__COVID-19__-current_2020_International-Journal-of-A 212
Coronavirus-Disease-2019__COVID-19__Pand_2020_American-Journal-of-Obstetrics 213
Coronavirus-Disease__COVID-19__-A-primer-fo_2020_The-American-Journal-of-Eme 214
Coronaviruses in animals and humans 215
Coronaviruses 216
Covid 19 epidemic  disease Characteritics in children 217
COVID 19 in INDIA Strategies to combat from 218
COVID-19 - Face Masks and Human-to-human Transmission 219
Covid-19 — Navigating the Uncharted 220
COVID-19 – the role of mass gatherings 221
COVID-19 A critical care perspective informed by lessons learnt from 222
COVID-19 a novel coronavirus and a novel 223
Covid-19 a puzzle with many missing pieces 224
COVID-19 and Blood Safety Help with a Dilemma 225
COVID-19 and diabetes Can DPP4 inhibition play a 226
COVID-19 and ImmunomodulatorImmunosuppressant Use in Dermatology 227
COVID-19 and Italy what next 228
COVID-19 and the anti-lessons of history 229
Covid-19- BSTIBSGAR decision tool for chest imaging in patients undergoing CT for acute surgical abdomen 230
COVID-19 Challenges to GIS with Big Data 231
COVID-19- combining antiviral and anti-inflammatory treatments 232
COVID-19 Computed Tomography Findings A Systematic Review and Meta-Analysis 233
COVID-19 consider cytokine storm syndromes and immunosuppression 234
COVID-19 Gastrointestinal Manifestations and Potential Fecal–Oral Transmission 235
COVID-19 Global radiation oncology’s targeted response for pandemic 236
COVID-19 HOW CAN A DEPARTMENT OF GENERAL SURGERY SURVIVE TO A 237
COVID-19 in children More than meets the eye 238
COVID-19 in children the link in the transmission chain 239
COVID-19 in Hemodialysis Patients A Report of 5 Cases 240
COVID-19 in Kidney Transplant Recipients 241
COVID-19 in Latin America The implications of the first confirmed case in Brazil 242
COVID-19 in patients with cardiovascular 243
COVID-19 in Singapore—Current Experience 244
COVID-19 Infection in a Patient with End-Stage Kidney Disease 245
COVID-19 Lessons from SARS and MERS 246
COVID-19 Melatonin as a Potential Adjuvant Treatment 247
COVID-19 Pandemic Staged Management of Surgical Services for Gynecology and 248
COVID-19 Personal Protective Equipment (PPE) for the emergency 249
COVID-19 pneumonia what has CT taught us 250
Covid-19 preparedness, decentralisation, and the hunt 251
COVID-19 preparing for superspreader potential among Umrah pilgrims to Saudi Arabia 252
Covid-19 school closures and bans on mass 253
COVID-19 spike-host cell receptor GRP78 binding site prediction 254
Covid-19 surge in cases in Italy and South Korea 255
COVID-19 therapeutic options for patients with Kidney Disease 256
COVID-19 through the lens of gerontology 257
Covid-19 Trump says risk to Americans is “very low” 258
COVID-19 Yet another coronavirus challenge in 259
COVID-19 Zoonotic aspects 260
COVID–19, Journal de bord–18022020– 261
COVID-19, the gendered impacts of the outbreak 262
COVID-19, una emergencia de salud pública mundial 263
COVID-19__lung_cancer_pathway_guidance_final 264
COVID-19__Epidemiology__Evolution__and-Cross-Disci_2020_Trends-in-Molecular- 265
COVID-19-infection-and-rheumatoid-arthritis__Faraway___2020_Autoimmunity-Rev 266
COVID-19-infection__Origin__transmission__and-charact_2020_Journal-of-Advanc 267
COVID-19—New Insights on a Rapidly Changing Epidemic 268
COVID-19__SARS-and-MERS__are-they-closely-_2020_Clinical-Microbiology-and-In 269
covid-19-testing-and-staff-retention-letter-29-march-2020 (1) 270
COVID-2019 the role of the nsp2 and nsp3 in its pathogenesis 271
Critical care crisis and some 272
Critical care management of adults 273
Current knowledge about the antivirals remdesivir (GS-5734) and GS- 274
Defining the Epidemiology of Covid-19 — Studies Needed 275
Dental journals and coronavirus disease (COVID-19) A current view 276
Dermatirtis and Covid 19 277
Detection of SARS-CoV-2 in Different Types of Clinical Specimens 278
Developing antibody tests for SARS-CoV-2 279
Developing Covid-19 Vaccines at Pandemic Speed 280
Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis 281
Development of epitope-based peptide vaccine against novel 282
Development of protection against coronavirus induced diseases. A review 283
Diabetes is a risk factor for the progression and prognosis of COVID-19 284
Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR, Reflecting on Experience from MERS-CoV 285
Diagnosis of severe respiratory infections 286
Diagnosis of the Coronavirus disease (COVID-19) rRT-PCR or CT 287
Diagnostic-value-and-dynamic-variance-of-serum_2020_International-Journal-of 288
DisinfectionChamber finalized 289
Do children need a longer time to shed SARS- 290
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection 291
Duration of quarantine in hospitalized patients with severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) i-2GFNCU3W 292
Duration of serum neutralizing antibodies for 293
Duration-of-quarantine-in-hospitalized-patients-with-severe_2020_Journal-of- 294
Dynamic-change-process-of-target-genes-by-RT-PCR-testing-of-S_2020_Clinica-C 295
Early epidemiological analysis of the coronavirus disease 296
Early Transmission Dynamics in Wuhan, China, 297
Early-dynamics-of-transmission-and-control-of-COVID-_2020_The-Lancet-Infecti 298
EASL-ESCMID-Position-Paper-on-COVID-19-and-the-liver-2-April-2020 299
Economic Impacts of Wuhan 2019-nCoV on China and the 300
COVID-19: Use Regional Anesthesia Wherever Possible 301
Effective Chemicals against Novel Coronavirus (COVID-19) in China 302
Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital 303
Effects of progressive muscle relaxation on anxiety and sleep quality in 304
Effects of temperature variation and humidity on the death of 305
Effects of the COVID-19 Outbreak in Northern Italy Perspectives from the Bergamo 306
Emergence of a novel coronavirus causing respiratory 307
Emergency management of nursing human resources and supplies to respond to 308
Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV 309
Enhancing Private Sector Health System Preparedness 310
Ensuring global access to COVID-19 vaccines 311
Enteric involvement of coronaviruses is faecal–oral 312
Enteropathogen co-infection in UK cats with diarrhoea 313
Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China 314
Epidemiologic Features and Clinical Course of Patients Infected 315
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, 316
Epidemiological characteristics and transmission model of 317
Epidemiological, clinical characteristics of cases of SARS-CoV-2 318
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronav-BLDUHJAH 319
Epidemiology, genome, and clinical features of the pandemic SARSCoV-2 a recent 320
Escaping Pandora’s Box — Another Novel Coronavirus 321
Espen expert statements and practical guidance for nutritional management of 322
Essential care of critical illness must not be forgotten in the COVID-19 pandemic 323
Estimates of the severity of coronavirus disease 2019- a model-based analysis 324
Estimating case fatality rates of COVID-19 325
Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries 326
Estimation of the reproductive number of novel coronavirus 327
Estimation of the Transmission Risk of the 2019‐nCoV and Its Implication forPublic Health Interventions 328
Ethical Outpatient Dermatology Care During the Coronavirus (COVID-19) Pandemic 329
Evaluation of the Effectiveness of Surveillance and Containment Measures for theFirst 100 Patients with COVID-19 i-N7FA529S 330
  331
Evidence of SARS-CoV-2 Infection in Returning 332
Evolving epidemiology and transmission dynamics of 333
Evolving reporting criteria of COVID-19 in 334
Evolving status of the 2019 novel coronavirus Infection proposal 335
Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology 336
Experience and suggestion of medical practices for burns during the 337
Experience-on-radiological-examinations-and-infection-_2020_Radiology-of-Inf 338
Exploring the reasons for healthcare workers infected with novel coronavirus disease 2019 (COVID-19) in China 339
Extracorporeal membrane oxygenation (ECMO) does it have a role in the 340
Facemaskshortageandthenovelcoronavirusdisease(COVID-19)outbreakReflectionsonpublichealthmeasures 341
Facing the COVID-19 outbreak What should we know and 342
Factsheet13.10.01-Fa-Final PDF 343
favipiravir-for-covid-19-(26-march-2020) 344
FDA authorizes emergency use of unapproved drugs to treat coronavirus - The Wash 345
Feasibility of controlling COVID-19 outbreaks by isolation of 346
Featuring-COVID-19-cases-via-screening-symptomatic-p_2020_Journal-of-Microbi 347
First Case of 2019 Novel Coronavirus in the United States 348
First case of Coronavirus Disease 2019 349
First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia 350
First respiratory transmitted food borne outbreak 351
First-known-person-to-person-transmission-of-severe-acute-respira_2020_The-L 352
From Bats to Human Lungs the Evolution of a Coronavirus The New Yorker 353
From-SARS-to-COVID-19__A-previously-unknown-SARS__related-coronavi_2020_One- 354
Full genome analysis of a novel type II feline coronavirus NTU156 355
Full-genome-evolutionary-analysis-of-the-novel-corona-viru_2020_Infection__G 356
Game consumption and the 2019 novel coronavirus 357
Gastrointestinal features of covid 19 358
Genetic and Molecular Biological Analysis of Protein-Protein Interactions in Coronavirus Assembly 359
Genetic diversity and evolution of SARS-CoV-2 360
Genetic-evolution-analysis-of-2019-novel-coronaviru_2020_Infection__Genetics 361
Genome-Composition-and-Divergence-of-the-Novel-Coronavirus_2020_Cell-Host__- 362
Genomic characterisation and epidemiology of 2019 novel 363
GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY 364
Genotype-and-phenotype-of-COVID-19__Thei_2020_Journal-of-Microbiology__Immun 365
Global coalition to accelerate COVID-19 clinical research in 366
Global epidemiology of coronavirus disease 2019 (COVID-19) disease incidence, daily cumulative index, mortality, a-5Q46QUF9 367
Going global – Travel and the 2019 novel coronavirus 368
Guidance for the management of myasthenia gravis (MG) and Lambert- 369
Guidance_for_Triage_of_Nonemergent_Surgical_Procedurespdf 370
Guidelines for pregnant women with suspected SARS-CoV-2 infection 371
Guillain-Barré syndrome associated with SARS-CoV-2 infection- causality or coincidence 372
Handling the COVID-19 pandemic in the oncological setting 373
Has China faced only a herald wave of SARS-CoV-2 374
Health security capacities in the context of COVID-19 375
Healthcare impact of COVID-19 epidemic in India A stochastic mathematical model 376
Hepatic-and-gastrointestinal-involvement-in-coronaviru_2020_Arab-Journal-of- 377
High-resolution computed tomography manifestations of COVID-19 378
Home care for cancer patients during COVID-19 pandemic the “double triage” 379
Homologous recombination within the spike glycoprotein 380
Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19 381
How Chinas Bat Woman Hunted Down Viruses from SARS to the New Coronavirus - S 382
How sick will the coronavirus make you 383
How South Korea Flattened the Coronavirus Curve - The New York Times 1 384
How to clean your home for coronavirus explained by an expert - Vox 1 385
How to face the novel coronavirus infection 386
How to link patients with suspicious COVID-19 to health system from the 387
Human Respiratory Viral Infections-2014 388
Hydroxychloroquine and azithromycin as a treatment of COVID-19 results of an openlabel 389
Identification and genetic characterization of porcine hemagglutinating encephalomyelitis virus from domestic pigle-H-IQ7IJW 390
Identification of 60-b-fluoro-homoaristeromycin as a potent inhibitor 391
Identification of a Novel Coronavirus in Patients 392
Identification of Kidney Transplant Recipients with Coronavirus 393
Identification of potential cross-protective epitope between a new type 394
Identification of the hyper-variable genomic hotspot for the 395
Identifying-factors-and-target-preventive-therapies-for-_2020_Saudi-Pharmace 396
IDM editorial statement on the 2019-nCoV 397
Imaging changes in severe COVID-19 pneumonia 398
Imaging changes of severe COVID-19 pneumonia in advanced stage 399
Imaging Features of Coronavirus disease 2019 (COVID-19) Evaluation on Thin-Section CT 400
Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area 401
Immunoinformatics-aided identification of T cell and B cell 402
Importation and Human-to-Human Transmission 403
Importing coronavirus disease 2019 (COVID-19) into China after 404
In Beijing, coronavirus 2019-nCoV has created a siege 405
In silico screening of Chinese herbal medicines with the potential to 406
Incidence-of-novel-coronavirus__2019-nCoV__infection_2020_Travel-Medicine-an 407
Infection à SARS-CoV-2COVID 19 et cancers solides  synthèse des 408
Infection par le SARS-CoV-2 chez les femmes enceintes. E´ tat des 409
Infographic_ The History of Pandemics by Death Toll 410
Initial Public Health Response and Interim Clinical Guidance for 411
Insight-into-2019-novel-coronavirus__-an-updated-_2020_International-Journal 412
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. 413
Instructions for controlling infection in anesthesia and surgery during coronavirus infection 414
Instructions for training to take care of yourself and others against COVID-19 in the office 415
Intensive care during the coronavirus 416
Interim Guidance for Healthcare Facilities Preparing for Community Transmission of COVID-19 in the United States 417
Internationally lost COVID-19 cases 418
Interpretation of the diagnosis and treatment plan of Corona Virus 419
Interrupting COVID-19 transmission by 420
Interventional Cardiology and Covid 19 421
Interventions to mitigate early spread of SARS-CoV-2 422
intranasal corticosteroids and covid19 423
Intranasal vaccination with recombinant receptor-binding domain of 424
Investigation of three clusters of COVID-19 in Singapore 425
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) 426
Is COVID-19 receiving ADE from other coronaviruses 427
Is the Coronavirus Airborne Should We All Wear Masks - The Atlantic 428
Journal of the Epidemiological Analysis Committee 429
Journey of a Thai Taxi Driver and Novel Coronavirus 430
Keratoconjunctivitis as the initial medical presentation of the novel 431
Kidney disease is associated with in-hospital death of patients with COVID-19 432
Labor and Delivery Guidance for COVID-19 433
Lack of small animal model hinders MERS coronavirus research 434
Le nouveau Coronavirus Covid-19  quels 435
Learning from the Past Possible Urgent Prevention and 436
Lessons From Italys Hospital Meltdown Every Day You Lose the Contagion Gets  437
Lessons learned from the 2019-nCoV epidemic on prevention of future 438
Letter from China covid-19 on the grapevine, on the 439
letter to Jahanpour final version 440
Levofloxacin prophylaxis in patients with newly diagnosed 441
Li Wenliang, a face to the frontline healthcare worker. The first 442
Lianhuaqingwen-exerts-anti-viral-and-anti-inflammatory-ac_2020_Pharmacologic 443
Liver injury in COVID-19 management and challenges 444
Lopinavir-ritonavir-did-not-shorten-the-duration-_2020_Journal-of-Microbiolo 445
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection, Lymphopenia in severe COVID-19-C06H8WK5 446
Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19) 447
Management of Cardiac Surgical Patients with Suspected or 448
mask and hand hygine covid 19 449
Measures for diagnosing and treating infections by a novel 450
Medical Education Adaptations Really Good Stuff for Educational Transition during a 451
Medical student involvement in the COVID-19 response 452
Medicine- before COVID-19, and after 453
MERS-CoV infection among healthcare workers and risk factors for 454
MERS-CoV infection is associated with downregulation of genes encoding 455
Message from the Editor- Stem Cell Science in the Time of COVID-19 456
Microneedle array delivered recombinant coronavirus vaccines- Immunogenicity and rapid translational development 457
  458
Middle East Respiratory Syndrome (MERS) coronavirus. What travel health advice should be given to Hajj pilgrims 459
Middle East Respiratory Syndrome Coronavirus Another Zoonotic 460
Middle East respiratory syndrome coronavirus 461
Middle-East-respiratory-syndrome-coronavirus__MERS-_2020_International-Journ 463
Mitigate the effects of home confinement on children during the COVID-19 outbreak 464
Modeling the dynamics of novel coronavirus 465
Modelling COVID-19 transmission- from data to intervention 466
Molecular basis of COVID-19 relationships in different species a one 467
Molecular-immune-pathogenesis-and-diagnosis-_2020_Journal-of-Pharmaceutical- 468
Monitoring behavioural insights related to COVID-19 469
Monitoring Transmissibility and Mortality of COVID-19 in Europe 470
N95 Respirators and Surgical Masks Blogs CDC 471
N95 Respirators vs Medical Masks for Preventing Influenza 472
Nafamostat is expected to prevent the transmission of new coronavirus infection (COVID-19) _ EurekAlert! Science News 473
Navigating the challenges of the COVID-19 outbreak perspectives from the 474
Nervous system involvement after infection with COVID-19 and other coronaviruses 475
Neuroinfection may potentially contribute to pathophysiology and clinical manifestations of COVID-19 476
Neurosurgery during the COVID-19 pandemic- update from Lombardy, northern Italy 477
Neutralizing-Antibodies-against-SARS-CoV-2-and-Other-Hu_2020_Trends-in-Immun 478
New coronavirus with “pandemic potential” sparks global surveillance efforts 479
New therapeutic opportunities for COVID-19 patients with Tocilizumab Possible correlation of 480
New-insights-on-the-antiviral-effects-of-chloroqu_2020_International-Journal 481
newsletter of IPA_1399_1_50 482
No time for dilemma- mass gatherings must be suspended 483
Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV 484
Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention 485
Not wearing masks to protect against co.. 486
Novel and Re-emerging Respiratory Viral Diseases-2008 487
Novel coronavirus  From discovery to clinical diagnostics 488
Novel coronavirus 2019 (COVID-19) Emergence and 489
Novel coronavirus Australian GPs raise concerns 490
Novel Coronavirus disease 2019 (COVID-19) The importance of recognising possible early ocular manifestation and us-6T8U1697 491
Novel coronavirus From discovery to clinical diagnostics 492
Novel coronavirus infection during the 2019–2020 epidemic preparing intensive care units—the experience in Sichuan-FXYIPBV5 493
Novel Coronavirus Infection in Hospitalized Infants 494
Novel coronavirus still of international concern 495
Novel Coronavirus-19 (COVID-19) in the Immunocompromised Transplant Recipient 496
Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing 497
Novel Vaccine Technologies Essential Components of an Adequate Response to Emerging Viral Diseases 498
Nowcasting and forecasting the potential domestic and 499
O Anestesiologista e a COVID-19 500
On the frontline against COVID-19 Community pharmacists’ contribution 501
On the Frontline of the COVID-19 Outbreak Keeping Patients on Long-Term Dialysis Safe 502
One in four coronavirus patients have NO symptoms 503
One size does not fit all – Patterns of vulnerability and resilience in the 504
ORIGINALStratégie pour la pratique de la chirurgiedigestive et oncologique en situationd’épidémie de COVID-19 505
Origins of MERS-CoVand lessons for 2019-nCoV 506
Outbreak of a new coronavirus what anaesthetists should know 507
Outbreak of coronavirus disease 2019 508
Outbreak of novel Corona virus (2019-nCoV); implications for travelers to Pakistan 509
Outcome-of-Coronavirus-spectrum-infections__SARS__M_2020_American-Journal-of 510
Overlapping and discrete aspects of the pathology and 511
Overview of guidance for endoscopy during the coronavirus disease 2019 (COVID-19) pandemic 512
Pages from [Human Respiratory Viral Infections-2014] 513
Pages from [Molecular and Cellular Biology of Viruses-2019] 514
Pages from [Polymerase Chain Reaction for Biomedical Applications-2016] 515
Pandemics and the great evolutionary mismatch 516
pannu_-_policy_brief_-_covid_series_-_turning_the_tables_on_pandemic_drugs_achieving_in-advance_therapeutics_-_v1 517
Passengers’ destinations from China low risk of 518
Pathogenicity-and-transmissibility-of-2019-nCoV-A-quick-ove_2020_Microbes-an 519
  520
Pathological findings of COVID-19 associated with acute 521
Patient education Coronavirus disease 2019 (COVID-19) (The Basics) 522
Patient Education_Novel Coronavirus Infection 523
Patients of COVID-19 may benefit from sustained lopinavir-combined 524
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog 525
Pay attention to situation of SARS-CoV-2 and TCM advantages in 526
Pediatric Middle East Respiratory Syndrome 527
Persistence of coronaviruses on inanimate surfaces and 528
Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020pdf 529
Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal 530
Physiotherapy management for COVID-19 in the acute hospital setting clinical 531
Planning and provision of ECMO services for severe ARDS 532
Policies on the use of respiratory protection for hospital health 533
Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19 534
Positive RT-PCR Test Results in Patients Recovered From COVID-19 535
Positive-rate-of-RT-PCR-detection-of-SARS-CoV-2-infection-in-_2020_Clinica-C 536
Potential inhibitors against 2019-nCoV coronavirus M protease from 537
Potential of large ‘first generation’ human-to-human 538
Potential role of inanimate surfaces for the spread of 539
Potential Maternal and Infant Outcomes from  540
Practical recommendations for critical care and anesthesiology 541
Practical-Strategies-Against-the-Novel-Coronavirus-and_2020_Archives-of-Medi 542
Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19) 543
Precautions and Procedures for Coronary and Structural Cardiac Interventions during the 544
Precautions for Operating Room Team Members during the COVID-19 Pandemic 545
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing 546
Predicting-commercially-available-antiviral-drugs-tha_2020_Computational-and 547
Predicting-the-impacts-of-epidemic-outbreaks-on-g_2020_Transportation-Resear 548
Preliminary-estimation-of-the-basic-reproduction-number-_2020_International- 549
  550
Preparation for Possible Sustained Transmission 551
Preparedness and vulnerability of African countries against 552
Preparing for theMost Critically Ill PatientsWith COVID-19 553
Pressrelease_EASL-ESCMID_PositionPaper_Covidliver_2April2020 554
Presumed Asymptomatic Carrier Transmission 555
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 556
Prevalence-of-comorbidities-in-the-novel-Wuhan-coro_2020_International-Journ 557
Preventing a covid-19 pandemic 558
Preventing intra-hospital infection and transmission of COVID-19 in healthcare 559
Preventive measures against MERS-CoV for Hajj pilgrims 560
Probable-Pangolin-Origin-of-SARS-CoV-2-Associated-with-the-_2020_Current-Bio 561
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19) A meta-analysis 562
Progress_stalled_on_coronaviru 563
Prolonged-Viral-Shedding-in-Feces-of-Pediatri_2020_Journal-of-Microbiology__ 564
Prophylactic Recommendation for Healthcare Workers during COVID-19 Pandemic  565
  566
Psychological crisis interventions in Sichuan Province during the 2019 novel coronavirus outbreak 567
Public Health Emergency Preparedness Globalizing Risk, 568
Public health management of personsPublic health management of persons Public health management of persons Public -T0Z__ZB5 569
Public health might be endangered by possible prolonged 570
Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan mental health 571
Pulmonary-Pathology-of-Early-Phase-2019-Novel-Coronaviru_2020_Journal-of-Tho 572
Purified coronavirus spike protein nanoparticles induce coronavirus 573
Radiological findings from 81 patients with COVID-19 574
Radiotherapy Workflow and Protection Procedures During the Coronavirus 575
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases 576
Rapid-random-access-detection-of-the-novel-SARS-coronavirus_2020_Journal-of- 577
Rational use of face masks in the COVID-19 pandemic 578
Real-time forecasts of the COVID-19 epidemic in China from 579
Recent advances and perspectives of nucleic acid detection for 580
Recent Progress in understanding 2019 Novel Coronavirus associated with 581
Receptor_for_new_coronavirus_found 582
RECOMENDACIONES DE CONSENSO SEPAR – AEER SOBRE LA 583
Recomendaciones prácticas para el manejo 584
Recomendaciones-en-el-manejo-de-la-pandemia-por-coronavirus-SARS-_2020_Nefro 585
Recomendaciones-sobre-el-manejo-cl-nico-de-la-infecci-n-por-el-_2020_Anales- 586
Recommandations pour la prise en charge chirurgicale des cancers 587
Recommendations and guidance for providing pharmaceutical care services 588
Recommendations for coronavirus infection in rheumatic diseases treated 589
Recommendations for the surgical management of gynecological cancers 590
Recommended-prophylactic-and-management-strategies-for_2020_Chronic-Diseases 591
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease 592
Recurrence-of-positive-SARS-CoV-2-RNA-in-C_2020_International-Journal-of-Inf 593
Redefining vulnerability in the era of COVID-19 594
Reflexiones Derivadas De La Pandemia Covid-19 595
Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia A Multicenter Study 596
Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study 597
Remdesivir and chloroquine effectively inhibit the recently 598
Remdesivir as a possible therapeutic option for the COVID-19 599
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro 600
Remdesivir-for-severe-acute-respiratory-syndrome-coro_2020_Travel-Medicine-a 601
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 602
Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study 603
Respiratory support for patients with COVID-19 infection 604
Advances in Experimental Medicine and Biology 605
Respiratory virus shedding in exhaled breath and efficacy of face masks 606
Respiratory viruses in mechanically ventilated patients: a pilot study 607
Responding to Covid-19 — A Once-in-a-Century Pandemic? 608
Response to the emerging novel coronavirus outbreak 609
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study 610
Risk-adapted Treatment Strategy For COVID-19 Patients  611
Rules on isolation rooms for suspected covid-19 cases in GP surgeries to be relaxed 612
SARS Coronavirus Redux 613
SARS to novel coronavirus – old lessons and new lessons 614
SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis
615
SARS-CoV-2: a time for clear and immediate action 616
SARS-CoV-2 and COVID-19 617
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor 618
SARS-CoV-2: fear versus data 619
SARS-CoV-2 in wastewater: potential health risk, but also data source 620
SARS-CoV-2 infection in children:Transmission dynamics and clinical characteristics 621
SARS-CoV-2 outbreak: How can pharmacists help? 622
SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients 623
SARS-CoV-2 Viral Load in Upper Respiratory Specimens  of Infected Patients 624
SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes 625
SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge 626
Title: Serial interval of novel coronavirus (COVID-19) infections  627
Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 628
Several potential risks of novel coronavirus (COVID-19) pneumonia outbreaks in hospitals  629
Severe acute respiratory syndrome (SARS) 630
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists 631
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges 632
Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong 633
Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids 634
Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China  635
Simulating and forecasting the cumulative confirmed cases of SARS-CoV-2 in china by Boltzmann function-based regression analyses 636
Society guideline links: Coronavirus disease 2019 (COVID-19)  637
SOGC Committee Opinion– COVID-19 in Pregnancy 638
Spatial epidemic dynamics of the COVID-19 outbreak in China 639
Clinical guide for the management of people with diabetes during the coronavirus pandemic  640
Clinical guide for the management of haemoglobinopathy patients (sickle cell disease and thalassaemia) during the coronavirus pandemic  641
Clinical guide for the management of acute burns patients during the coronavirus pandemic  642
Clinical guide for anaesthesia service reorganisation during the coronavirus pandemic  643
Clinical guide for the management of emergency department patients during the coronavirus pandemic  644
Clinical guide for the management of paediatric patients during the coronavirus pandemic  645
Clinical guide for the management of noncoronavirus patients requiring acute treatment: Cancer
646
Clinical guide for the management of cardiology patients during the coronavirus pandemic  647
Clinical guide for the management of cardiothoracic surgery patients during theCoronavirus pandemic  648
Coronavirus: principles for increasing the nursing workforce in response to exceptional increased demand in adult critical care   649
Clinical guide for the management of noncoronavirus patients requiring acute
treatmentgeneral and internal medicine during the coronavirus pandemic
650
Clinical guide for the management of critical care patients during the coronavirus pandemic
651
Clinical guide for the management of patientsrequiring plastics treatment during the Coronavirus pandemic  652
Clinical guide for the management of vascular surgery patients during the Coronavirus pandemic  653
Clinical guide for the management of neurotrauma patients during the coronavirus pandemic  654
Clinical guide for management of patients requiring oral and maxillofacial surgery during the coronavirus pandemic  655
Clinical guide for the management of ophthalmology patients during the coronavirus pandemic  656
Clinical guide for the management of trauma and orthopaedic patients during the coronavirus pandemic
 
657
Clinical guide to managing the patient with a cough and a temperature during the coronavirus pandemic 658
Clinical guide: PPE for care of women with known or suspected coronavirus in labour  659
Clinical guide for the management of Radiology patients during the coronavirus pandemic  660
Clinical guide for the management of surgical patients during the coronavirus pandemic  661
Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection 662
Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, singlecentre, observational cohort study 663
Appendix: Biphasic decay of infectious SARS-CoV-2 population 664
Stability of SARS-CoV-2 in different environmental conditions  665
Stability of SARS-CoV-2 in different environmental conditions  666
Steps Healthcare Facilities Can Take Now to Prepare for Coronavirus Disease 2019 (COVID-19) 667
Strategic plan for management of COVID-19 in paediatric haematology and oncology departments 668
Strategies to Prevent the Spread of COVID-19 in Long-Term Care Facilities (LTCF) 669
Strategies to promote better sleep in these uncertain times 670
Strategy for the practice of digestive andoncological surgery during the Covid-19epidemic 671
Structural and molecular modeling studies reveal a new mechanism 672
structural_studies_of_coronavirus_fusion_proteins 673
Structural-basis-of-SARS-CoV-2-3CLpro-and-anti-COVID_2020_Journal-of-Pharmac 674
Structure, Function, and Antigenicity of the SARSCoV- 675
Structure-analysis-of-the-receptor-bi_2020_Biochemical-and-Biophysical-Resea 676
Suggestions on the prevention of COVID-19 for health care workers in department of 677
Surveillance to improve evidence for community control decisions during the COVID-19 678
Surviving Sepsis Campaign- guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) 679
Taking the right measures to control COVID-19 680
Teaser Recent advances in the research and development of small-molecule anti-human 681
Teicoplanin__an-alternative-drug-for-the-_2020_International-Journal-of-Anti 682
Temporal profiles of viral load in posterior oropharyngeal 683
Ten Weeks to Crush the Curve 684
TH17-responses-in-cytokine-storm-of-COVID-19___2020_Journal-of-Microbiology- 685
The 2019 Coronavirus Learning Curves, Lessons, and the Weakest Link  686
The 2019-new coronavirus epidemic evidence for virus evolution  687
The Anesthesiologist and COVID-19 688
The Battle Against Coronavirus Disease 689
The cancellation of mass gatherings (MGs) Decision making in the time of 690
The continuing 2019-nCoV epidemic threat of novel coronaviruses 691
The coronavirus 2019-nCoV epidemic Is hindsight 2020 692
The course of clinical diagnosis and treatment of a case infected 693
The Covid-19 epidemic 694
The COVID-19 Pandemic Important Considerations for Contact Lens Practitioners 695
The COVID-19 pandemic through the lens of a gastroenterology fellow looking for the 696
The deadly coronaviruses, The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China 697
The effect of control strategies to reduce social mixing on 698
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak 699
The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus 700
The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease) 701
The enlightenment from two cases of asymptomatic infection withSARS-CoV-2: is it safe after 14 days of isolation? 702
The GReek study in the Effects of Colchicine in COvid-19 complications prevention 703
The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care 704
The impact of the COVID-19 epidemic on the utilization of emergency dental services 705
The importance of designingand implementingparticipatory surveillancesystem: An approach as earlydetection and prevention ofnovel coronavirus(2019-nCov) 706
The untold origin story of theN95 mask 707
The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients 708
The next bigthreattoglobalhealth?2019novelcoronavirus(2019-nCoV):Whatadvicecanwegivetotravellers?–InterimrecommendationsJanuary2020,fromtheLatin- mericansocietyforTravelMedicine(SLAMVI)  709
The Novel Chinese Coronavirus (2019-nCoV) Infections challenges for 710
The novel Coronavirus (SARS-CoV-2) is a one health issue 711
The novel Coronavirus (SARS-CoV-2) 712
The Novel Coronavirus Originating inWuhan, China 713
The progress of 2019 Novel Coronavirus (2019-nCoV) event 714
SARS-CoV-2 infection in children Transmission dynamics and clinical 715
The psychological impact of the COVID-19 epidemic on college 716
The risk factors associated with MERS-CoV patient fatality A global survey 717
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin 718
The versetile heparin in covid 19 719
The-cardiovascular-burden-of-coronavirus-disease-2019_2020_International-Jou 720
The-COVID-19-pandemic__Implications-for-_2020_Journal-of-the-American-Societ 721
Seroprevalence of MERS-CoV in healthy adults in western SaudiArabia, 2011–2016 722
The-deadly-coronaviruses__The-2003-SARS-pandemic-and-the-_2020_Journal-of-Au 723
The-epidemiology-and-pathogenesis-of-coronavirus-disea_2020_Journal-of-Autoi 724
The-epidemiology__diagnosis-and-treatm_2020_International-Journal-of-Antimic 725
The-Middle-East-Respiratory-Syndrome-C_2020_Emerging-and-Reemerg 726
The-outbreak-of-Coronavirus-Disease-2019__COVID-1_2020_Journal-of-Infection 727
The-Possible-of-Immunotherapy-for-COVID-19__a-S_2020_International-Immunopha 728
The-SARS-CoV-2-outbreak-from-a-one-health-perspective_2020_One-Health 729
The-SARS-CoV-2-outbreak__what-we_2020_International-Journal-of-Infectious-Di 730
The-spike-glycoprotein-of-the-new-coronavirus-2019-nCoV-contai_2020_Antivira 731
The-use-of-anti-inflammatory-drugs-in-the-treatment-of-people-w_2020_Clinica 732
Thoracic Imaging in COVID-19 Infection 733
Thrombocytopenia is associated with severe coronavirus disease 2019 734
Time Course of Lung Changes On Chest CT During Recovery From 2019 Nove 735
Timely blood glucose management for the outbreak 736
Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed 737
Timely research papers about COVID-19 in China 738
Title Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection  739
Title Potential Interventions for Novel Coronavirus in 740
Towards improving clinical management of Middle East respiratory syndrome coronavirus infection  741
Tracking the transmission and evolution of MERS-CoV 742
Traditional Chinese medicine is a resource for drug discovery against 743
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia a descriptive genomic study 744
Transmission dynamics and evolutionary history of 2019-nCoV 745
Transmission of 2019-nCoV Infection 746
Transmission potential and severity of COVID-19 in South Korea 747
Transmission potential of the novel coronavirus (COVID-19) 748
Transmission-of-COVID-19-in-the-terminal-stage-_2020_International-Journal-o 749
Treatment and vaccines for severe acute respiratory 750
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 751
Treatment with interferon-a2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques 752
Trust is a key factor in the willingness of health professionals to work during the  753
Turbulent Gas Clouds and Respiratory Pathogen Emissions Potential Implications for Reducing Transmission of COVID-19 754
Understanding COVID-19 new diagnostic guidelines - a message of reassurance from an internal medicine doctor in Shanghai 755
Understanding of COVID-19 based on current 756
Understanding of guidance for acupuncture and moxibustion 757
Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate-T5875BIS 758
Unknown unknowns – COVID-19 and potential global mortality 759
Unveiling the Origin and Transmission of 2019-nCoV 760
Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in 761
Updates on Wuhan 2019 Novel Coronavirus Epidemic  762
Upper airway symptoms in coronavirus disease 2019 763
urgent-emergency-msk-conditions-requiring-onward-referral-23-march-2020-updated (1) 764
US Emergency Legal Responses to Novel Coronavirus 765
Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 766
Using observational data to quantify bias of traveller-derived 767
Vicarious traumatization in the general public, members, and non-members 768
Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens What have we 769
Virtual-screening-and-repurposing-of-FDA-approved-drugs-again_2020_Life-Scie 770
What are the risks of COVID-19 infection in pregnant women 771
What goes on board aircraft Passengers include Aedes, Anopheles, 2019-nCoV 772
What if the cure for the coronavirus we...mple as taking zinc – NaturalNews 773
What is the role of rheumatologists in the era of COVID-19 774
What next for the coronavirus response 775
What Should Gastroenterologists and Patients Know About COVID-19 776
What We Know So Far (As of March 26, 2020) About COVID-19 – An MRT Point of 777
What"s new in emergency medicine 778
What"s new in family medicine 779
What"s new in hospital medicine 780
What"s new in infectious diseases 781
What"s new in primary care 782
Where did SARSCoV-2 come from 783
WHO Director-Generals opening remarks at the media briefing on COVID-19 - 1 Apr 784
Why inequality could spread COVID-19 785
Why is it difficult to accurately predict the COVID-19 786
Why-are-pregnant-women-susceptible-to-COVID-19___2020_Journal-of-Reproductiv 787
Working through the COVID-19 outbreak Rapid review and 788
World-Health-Organization-declares-global-emergency__A_2020_International-Jo 789
Would everyone wearing face masks help us slow the pandemic 790
Wuhan novel coronavirus (COVID-19) why global control is 791
US Emergency Legal Responses to Novel Coronavirus Balancing Public Health and Civil Liberties 792
Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors 793
Pulmonary High-Resolution Computed Tomography (HRCT) Findings of Patients with Early-Stage Coronavirus Disease 2019 (COVID-19) in Hangzhou, China 794
Respiratory virus shedding in exhaled breath and efficacy of face masks 795
Economic and Monetary Union at twenty: a stocktaking of a tumultuous second decade: introduction 796
Porcine deltacoronavirus infection alters bacterial communities in the colon and feces of neonatal iglets 797
Coronaviren: von der banalen Erkältung zum schweren Lungenversagen Chronologie einer Pandemie 798
The species Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and namingit  799
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B  800
Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection 801
Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak 802
Coronavirus 2019-nCoV: A brief perspective from the front line 803
Clinical characteristics and imaging manifestations of the 2019 novelcoronavirus disease (COVID-19):A multi-center study in Wenzhou city,Zhejiang, China 804
Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2 805
Characteristics of COVID-19 infection in Beijing 806
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts 807
Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection 808
Corona Virus International Public Health Emergencies: Implications for Radiology Management 809
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia 810
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus 811
A Review of Coronavirus Disease-2019 (COVID-19) 812
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) 813
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia 814
Unveiling patterns of viral pathogen infection in free-ranging carnivores of northern Portugal using a complementary methodological approach 815
Cross‐species transmission of the newly identified coronavirus 2019‐nCoV 816
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event 817
Novel coronavirus: From discovery to clinical diagnostics 818
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission 819
Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020? 820
Diagnostic performance of chest CT to differentiate COVID‑19 pneumonia in non‑high‑epidemic area in Japan 821
Use of in situ simulation to evaluate the operational readiness of a high-consequence infectious disease intensive care unit 822
The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China 823
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion 824
A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine 825
Liver injury during highly pathogenic human coronavirus infections 826
The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice 827
Coronavirus: the spread of misinformation 828
„Coronavirus disease 2019“ (COVID-19): update für Anästhesisten und Intensivmediziner März 2020 829
An Epidemiological Study on COVID-19: A Rapidly Spreading Disease 830
CT image of novel coronavirus pneumonia: a case report 831
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia inWuhan, China 832
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review 833
COVID‑19 pneumonia: infection control protocol inside computed tomography suites 834
SARS-CoV-2 and COVID-19: The most important research questions 835
Potential impact of seasonal forcing on a SARS-CoV-2 pandemic 836
Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients 837
Clinical features of pediatric patients with COVID‑19: a report of two family cluster cases 838
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 839
Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals 840
Coronavirus Disease: A Review of a New Threat to Public Health 841
Immune Predictors of Mortality After Ribonucleic Acid Virus Infection 842
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study 843
The psychological impact of quarantine and how to reduce it: rapid review of the evidence 844
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status 845
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan 846
Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter 847
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation 848
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding 849
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019 850
Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein 851
Genetic characterization and phylogenetic analysis of porcine deltacoronavirus (PDCoV) in Shandong Province, China 852
Swine acute diarrhea syndrome coronavirus (SADS-CoV) antagonizes interferon-β production via blocking IPS-1 and RIG-I 853
Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospitalin Singapore 854
Chest computed tomography in children with COVID-19 respiratory infection 855
Analyzing the epidemiological outbreak of COVID‐19: A visual exploratory data analysis approach 856
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records 857
Containing 2019-nCoV (Wuhan) coronavirus 858
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines 859
First Case of 2019 Novel Coronavirus in the United States 860
Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) 861
Clinical characteristics of 24 asymptomatic infections with COVID- 19 screened among close contacts in Nanjing, China 862
Transmission routes of 2019-nCoV and controls in dental practice 863
Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong 864
Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak 865
Pathogen-specific risk factors in acute outbreaks of respiratory disease in calves 866
Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal 867
Pathogenicity and transmissibility of 2019-nCoVdA quick overview and comparison with other emerging viruses 868
Is COVID-19 receiving ADE from other coronaviruses? 869
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China 870
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future 871
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases 872
MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018 873
First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan 874
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus 875
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection 876
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry 877
Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species 878
Anewcoronavirus associatedwithhuman respiratory disease inChina 879
Apneumoniaoutbreak associatedwitha newcoronavirus ofprobablebat origin 880
Important roles of dietary taurine, creatine, carnosine, anserine and 4‑hydroxyproline in human nutrition and health 881
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges 882
Host AAA  ATPase TER94 Plays Critical Roles in Building the Baculovirus Viral Replication Factory and Virion Morphogenesis 883
Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact 884
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents 885
Isolation and characterization of a variant subgroup GII-a porcine epidemic diarrhea virus strain in China 886
Camelid type I interferons: Identification and functional characterization of interferon alpha from the dromedary camel (Camelus dromedarius) 887
2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus 888
Bacterial Pneumonia in Dogs and Cats: An Update 889
Global challenges in health and health care for nurses and midwives everywhere 890
Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design 891
Finding an Accurate Early Forecasting Model from Small Dataset: A Case of 2019-nCoV Novel Coronavirus Outbreak 892
A recombinant infectious bronchitis virus from a chicken with a spike gene closely related to that of a turkey coronavirus 893
Novel findings from a beta coronavirus outbreak on an American Miniature Horse breeding farm in upstate New York 894
Detection and Molecular Characterization of BCoVs Circulating in Central China Based on the Full-length Spike Gene 895
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study 896
Q&A: The novel coronavirus outbreak causing COVID-19 897
A mathematical model for simulating the phase-based transmissibility of a novel coronavirus 898
Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak 899
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 900
Characterization of spike glycoprotein ofSARS-CoV-2 on virus entry and its immunecross-reactivity with SARS-CoV 901
Is nicotine exposure linked to cardiopulmonaryvulnerability to COVID-19 in the general population? 902
Coronavirus disease 2019: What we know? 903
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID‑19) 904
Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review 905
Common CT Findings of Novel Coronavirus Disease 2019 (COVID-19): A Case Series 906
Application of personal-oriented digital technology in preventing transmission of COVID-19, China 907
Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis 908
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update 909
Development Path and Urgency of further Strengthening Construction of Public Hospitals Based on Novel Coronavirus Pneumonia Treatment 910
Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China 911
Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection 912
Responding to COVID-19 913
Mutterschutz – auch im Zeitalter der Coronakrise 914
Focus on Mental Health During the Coronavirus (COVID-19) Pandemic: Applying Learnings from the Past Outbreaks 915
Searching an Effective Therapy for the Coronavirus Pandemic: Do We See Light at the End of the Tunnel? 916
Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond 917
CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19) 918
COVID-19 containment: China provides important lessons for global response 919
Practical considerations for performing regional anesthesia: lessons learned from the COVID-19 pandemic Conside´rations pratiques re´gionale: les lec¸ons tire´es de la pande´mie de COVID-19 pour lare´alisation de l’anesthe´sie 920
Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China 921
Epidemiological data from the COVID-19 outbreak, real-time case information 922
Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2 923
Factors Associated With Mental Health Outcomes Among Health CareWorkers Exposed to Coronavirus Disease 2019 924
Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists 925
Coronavirus disease 2019: initial chest CT findings 926
Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the  Coronavirus Disease 2019 (COVID-19)Treatment of 927
Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment 928
The effect of timing on community acquired respiratory virusinfection mortality epidemiological surveyhematopoietic stem cell transplantation: a prospectiveduring the first year after allogeneic 929
Neurological Complications of Coronavirus Disease(COVID-19): Encephalopathy 930
A Bibliometric Analysis of COVID-19 Research Activity: A Call for Increased Output 931
Understanding the Mosaic of COVID-19: A Review of the Ongoing Crisis 932
Insights from nanomedicine into chloroquine efficacy against COVID-19 933
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions 934
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation 935
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review 936
Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study 937
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBDprotein as a viral attachment inhibitor and vaccine 938
AI-Driven Tools for Coronavirus Outbreak: Need of Active Learning and Cross-Population Train/Test Models on DataMultitudinal/Multimodal 939
Coronavirus disinfection in histopathology 940
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools 941
Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than coronavirus‐associated illnessesneutralizing antibodies in identifying 942
Potential interventions for novel coronavirus in China: A systematic review 943
Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV 944
Immune responses in COVID-19 and potential vaccines:Lessons learned from SARS and MERS epidemic 945
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19) 946
COVID-19: The outbreak caused by a new coronavirus 947
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) 948
Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis 949
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic 950
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19) 951
Comparison of relative expressions of genes involved in iron acquisition and regulation in fluoroquinolone-resistant and wild-type Campylobacter jejuni 952
Coinfection with porcine circovirus type 2 and Streptococcus suis serotype 2 enhances pathogenicity by dysregulation of the immune responses in piglets 953
Pathogenicity of a variant duck orthoreovirus strain in Cherry Valley Ducklings 954
A quickly, effectively screening process of novel corona virus disease 2019 (COVID-19) in children in Shanghai, China 955
COVID-19: The outbreak caused by a new coronavirus 956
Severe underlying liver diseases and high mortality associated with Laribacter hongkongensis bacteremia 957
Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection 958
Aureimonas altamirensis masquerading as Brucella spp. in a blood culture from a 68-year-old male with cancer 959
Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli   hospitals (CANWARD, 2007–2017)clinical 960
Matrix-assisted laser desorption ionization-time of flight mass spectrometry can be used to identify Helicobacter cinaedi 961
Clinical impact of molecular identification of rare yeasts and nonsporulating molds recovered in culture from clinical specimens 962
Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development 963
Influence of interferon-based drugs on immunological indices in specific prevention 964
Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions 965
Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases 966
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A StatisticalPublicly Available Case Data Analysis of 967
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China 968
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China 969
Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang, China: February 13–23, 2020 970
Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19) 971
Novel Coronavirus Outbreak in Wuhan, China, 2020:Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations 972
Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Analysis of the Early OutbreakModelling 973
Discovering drugs to treat coronavirus disease 2019 (COVID-19) 974
Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis 975
A 25-Year-Old Sample Contributes the Complete GenomeSequence of Avian Coronavirus Vaccine Strain ArkDPI,Reisolated from Commercial Broilers in the United States 976
Complete Genome Sequence of Avian Coronavirus Strain GA08 977
Disrupting the association of Autographa californica multiple egress of nucleocapsids and intranuclear microvesicles formationnucleopolyhedrovirus Ac93 with cellular ESCRT-III/Vps4 hinders nuclear 978
Hepatitis E viral infection causes testicular damage in mice 979
Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway 980
CSFV protein NS5A activates the unfolded protein response to promote viral replication 981
Inhibitors of the interferon response increase the replication of gorilla simian foamy viruses 982
Middle East Respiratory Syndrome Coronavirus Transmission 983
Porcine Deltacoronavirus Infection and Transmission in Poultry, United States1 984
Interferon-stimulated genes inhibit caprine parainfluenza virus type 3 replication in Madin-Darby bovine kidney cells 985
Experimental listeriosis: A study of purinergic and cholinergic inflammatory pathway 986
Evaluation of a novel inactivated vaccine against duck circovirus in muscovy ducks 987
Gastrointestinal Symptoms & stool viral RNA positivity rate in COVID-19 988
Poxvirus encoded eIF2α homolog, K3 family proteins, is a key determinant of poxvirus host species specificity 989
Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition) 990
Which lessons shall we learn from the 2019 novel coronavirus outbreak? 991
Synthesis and structure-activity relationship studies ofa-naphthoflavone derivatives as CYP1B1 inhibitors 992
Fluorine-substituted tetracationic ABAB-phthalocyanines for efficient bacteria photodynamic inactivation of Gram-positive and Gram-negative 993
The discovery of novel indazole derivatives as tubulin colchicine sitebindingand in vivo agents that displayed potent antitumor activity both in vitro 994
through peroxisome proliferator-activated receptor g modulation 995
Depletion of miR-380 mitigates human bronchial epithelial cells injury toimprove chronic obstructive pulmonary disease through targeting CHRNA4 996
LGI3 is secreted and binds to ADAM22 via TRIF-dependent NF-κB pathwayin response to LPS in human keratinocytes 997
Increased levels of inflammatory biomarker CX3CL1 in patients with chronicobstructive pulmonary disease 998
Physical training prior to myocardial infarction potentializes stem celltherapy, response in hypertensive ratsSDF-1/CXCR4 axis activation and inhibits the vasoconstrictor 999
A time delay dynamic system with external source for the local outbreak of 2019-nCoV 1000
Visualising the expansion and spread of coronavirus disease 2019 by cartograms 1001
Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China 1002
Finding equipoise: CEPI revises its equitable access policy 1003
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa 1004
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses 1005
Does SARS‐CoV‐2 has a longer incubation period than SARS and MERS? 1006
A numerical study of ventilation strategies for infection risk mitigation in general inpatient wards 1007
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding 1008
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV 1009
MiR-10a-5p-Mediated Syndecan 1 Suppression Restricts Porcine Hemagglutinating Encephalomyelitis Virus Replication 1010
A Novel Coronavirus from Patients with Pneumonia in China, 2019 1011
2019 novel coronavirus of pneumonia inWuhan, China: emerging attack and management strategies 1012
Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory 1013
Does SARS‐CoV‐2 has a longer incubation period than SARS and MERS? 1014
A numerical study of ventilation strategies for infection risk mitigation in general inpatient wards 1015
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding 1016
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV 1017
MiR-10a-5p-Mediated Syndecan 1 Suppression Restricts Porcine Hemagglutinating Encephalomyelitis Virus Replication 1018
A Novel Coronavirus from Patients with Pneumonia in China, 2019 1019
2019 novel coronavirus of pneumonia inWuhan, China: emerging attack and management strategies 1020
Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory 1021
Genomic variance of the 2019‐nCoV coronavirus 1022
Expression Pattern Analysis of Antiviral Genes and Inflammatory Cytokines in PEDV-Infected Porcine Intestinal Epithelial Cells 1023
2019 Novel coronavirus: where we are and what we know 1024
Effects of misleading media coverage on public health crisis: a case of the 2019 novel coronavirus outbreak in China 1025
Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child 1026
Bat-borne viruses in Africa: a critical review 1027
The Effects of Social Media Use on Preventive Behaviors during Infectious Disease Outbreaks: The Mediating Role of Self-relevant Emotions and Public Risk Perception 1028
Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages 1029
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China 1030
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study 1031
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster 1032
Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor 1033
The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus 1034
Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study 1035
Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV 1036
Transmission dynamics and evolutionary history of 2019‐nCoV 1037
Public awareness of coronavirus in Al-Jouf region, Saudi Arabia 1038
Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China 1039
Non‑influenza respiratory viruses in adult patients admitted with influenza‑like illness: a 3‑year prospective multicenter study 1040
Respiratory viruses in mechanically ventilated patients: a pilot study 1041
The global spread of 2019-nCoV: a molecular evolutionary analysis 1042
Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients Directives concre`tes `a l’intention des e´quipes de soins intensifs et d’anesthe´siologie prenant soin de patients atteints du coronavi 1043
The first two cases of 2019‐nCoV in Italy: Where they come from? 1044
Development of an indirect ELISA for detecting porcine deltacoronavirus IgA antibodies 1045
Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China 1046
PEDV enters cells through clathrin-, caveolae-, and lipid raft-mediated endocytosis and traffics via the endo-/lysosome pathway 1047
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea 1048
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement 1049
Emerging coronaviruses: Genome structure, replication, and pathogenesis 1050
Associations of the IL-1B level, IL-1A and IL-1B gene polymorphisms andankylosing spondylitis risk in a Chinese Han population 1051
Chemokine (C-C motif) ligand 2 and coronary artery disease: Tissueexpression of functional and atypical receptors 1052
Cell proliferation activity delineated by molecular docking of four F. Gmelnewcompounds isolated from the aerial parts of Suaeda monoica Forssk. ex. J. 1053
Dispensing errors and self-medication practice observed by communitypharmacists in Jordan 1054
Time and sex dependency of hemodynamic, renal, and survivabilityeffects of endotoxemia in rats 1055
Optimization and evaluation of novel tetrahydropyrido[4,3-d]pyrimidine fibrosisderivatives as ATX inhibitors for cardiac and hepatic 1056
A second-generation micro/nano capsules of an endogenous primaryun-antioxidant compoundsmetabolised bile acid, stabilized by Eudragit-alginate complex with 1057
Association of OprF mutant and disturbance of biofilm and pyocyaninvirulence in pseudomonas aeruginosa 1058
Evidence that changes in antimicrobial peptides during tuberculosis arerelated to of immune-endocrine mediatorsdisease severity, clinical presentation, specific therapy and levels 1059
Pathogen-specific risk factors in acute outbreaksof respiratory disease in calves 1060
Association between ABCB1, ABCG2 carrier protein and COX-2 enzymegene polymorphisms and breast cancer risk in a Turkish population 1061
Semisynthesis and biological evaluation of some novel Mannich basederivatives agentsagentsderived from a natural lignan obovatol as potential antifungal 1062
Gga-miR-30d regulates infectious bronchitis virus infection by targetingUSP47 in HD11 cells 1063
Attenuation and characterization of porcine enteric alphacoronavirus strainGDS04 via serial cell passage 1064
Origin recognition complex subunit 1 regulates cell growth and metastasis inglioma by altering activation of ERK and JNK signaling pathway 1065
Combining Procalcitonin and Rapid Multiplex Respiratory VirusTesting for Severe Acute Respiratory InfectionAntibiotic Stewardship in Older Adult Patients With 1066
Nucleocapsid Protein Recruitment to Replication-TranscriptionComplexes Plays a Crucial Role in Coronaviral Life Cycle 1067
Coronavirus disease 2019 Mehr Sicherheit durch kompakte Fakten und Handlungsempfehlungen 1068
Lidocaine during intubation and extubation in patients with coronavirus disease (COVID-19) 1069
Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19) 1070
Chest computed tomography images of early coronavirus disease (COVID-19) 1071
New coronavirus: new challenges for pediatricians 1072
Correction to: COVID-19: a novel coronavirus and a novel challenge for critical care 1073
Using echocardiography to guide the treatment of novel coronavirus pneumonia 1074
How to face the novel coronavirus infection during the 2019–2020 epidemic: the experience of Sichuan Provincial People’s Hospital 1075
The impact of high-flow nasal cannula (HFNC) on coughing distance: implications on its use during the novel coronavirus disease outbreak 1076
Take precautions beforehand: calling for clinical trials of pediatric drugs for treating coronavirus disease 2019 1077
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19 1078
Coronavirus: just imagine… 1079
The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges 1080
Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue 1081
Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China 1082
Practice of novel method of bedside postpyloric tube placement in patients with coronavirus disease 2019 1083
Simulation as a tool for assessing and evolving your current personal protective equipment: lessons learned during the coronavirus disease (COVID-19) pandemic 1084
In reply: Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19) 1085
Intensive care during the coronavirus
epidemic
1086
Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus 1087
Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients Directives concre`tes `a l’intention des e´quipes de soins intensifs et d’anesthe´siologie prenant soin de patients atteints du coronavi 1088
COVID-19: a novel coronavirus and a novel challenge for critical care 1089
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement 1090
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019 1091
Coronavirus disease 2019“ (COVID-19): update für Anästhesisten und Intensivmediziner März 2020 1092
Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020 1093
Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak 1094
The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China 1095
Clinical features of severe pediatric patients with coronavirus disease 2019 inWuhan: a single center’s observational study 1096
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) 1097
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists 1098
Practical considerations for performing regional anesthesia: lessons learned from the COVID-19 pandemic Conside´rations pratiques pour lare´alisation de l’anesthe´sie re´gionale: les lec¸ons tire´es de la pande´mie de COVID-19 1099
German recommendations for critically ill patients with COVID-19 1100
Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients Se´curite´ et efficacite´ de diffe´rents modes d’anesthe´sie pour des parturientes infecte´es par la COVID-19 accou 1101
Personal Protection Prior to Preoperative Assessment—Little more an anaesthesiologist can do to prevent SARS- CoV-2 transmission and COVID-19 infection 1102
COVID-19 and the RAAS—a potential role for angiotensin II? 1103
Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis 1104
VID-19 pandemic: the 3R’s (reduce, refine, and replace) of personal protective equipment (PPE) sustainability 1105
Critical care management of adults with community-acquired severe respiratory viral infection 1106
How to transform a general hospital into
an “infectious disease hospital” during the
epidemic of COVID-19
1107
Mutterschutz – auch im Zeitalter der Coronakrise 1108
Diagnosis of severe respiratory infections in immunocompromised patients 1109
Preparing for a COVID -19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore Se pre´parer pour la pande´mie de COVID -19: revue des moyens de´ploye´s dans un bloc ope´ratoire d’un grand hopital tertiai 1110
Social distancing: implications for the operating room in the face of COVID-19 1111
Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit 1112
COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China 1113
What we do when a COVID-19 patient needs an operation: operating room preparation and guidance 1114
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target 1115
Clinical features of pediatric patients with COVID‑19: a report of two family cluster cases 1116
Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19 1117
Acute kidney injury in SARS-CoV-2 infected patients 1118
A case of a readmitted patient who recovered from COVID-19 in Chengdu, China 1119
Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 1120
Respiratory viruses in mechanically ventilated patients: a pilot study 1121
The application of strong matrix management and PDCA cycle in the management of severe COVID-19 patients 1122
Critical care crisis and some recommendations during the COVID-19 epidemic in China 1123
Clear plastic drapes may be effective at limiting aerosolization and droplet spray during extubation: implications for COVID-19 1124
Preparing for COVID-19: early experience from an intensive care unit in Singapore 1125
European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID‑19 infection 1126
Challenges and countermeasures for organ donation during the SARS-CoV-2 epidemic: the experience of Sichuan Provincial People’s Hospita 1127
Imaging changes of severe COVID-19 pneumonia in advanced stage 1128
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series 1129
Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID‑19 pneumonia: retrospective case series 1130
How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital 1131
Common breaches in biosafety during donning and doffing of protective personal equipment used in the care of COVID-19 patients 1132
Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China 1133
Mental health advice for frontline healthcare providers caring for patients with COVID-19 1134
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan 1135
Familial cluster of COVID-19 infection from an asymptomatic 1136
Covid-19 in China: ten critical issues for intensive care medicine 1137
Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province 1138
The model of epidemic (COVID-19) prevention and control in rural of China 1139
Special attention to nurses’ protection during the COVID-19 epidemic 1140
Treatment of COVID-19: old tricks for new challenges 1141
Locating and repurposing anesthetic machines as intensive care unit ventilators during the COVID-19 pandemic 1142
Clinicolaboratory study of 25 fatal cases of COVID-19 inWuhan 1143
A new clinical trial to test high-dose vitamin C in patients with COVID-19 1144
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients fromWuhan, China 1145
COVID-19 pneumonia: different respiratory treatments for different phenotypes? 1146
Imaging changes in severe COVID-19 pneumonia 1147
Findings of lung ultrasonography of novel corona virus pneumonia during the 2019–2020 epidemic 1148
Project IDentif.AI: Harnessing Artificial Intelligence toRapidly Optimize Combination Therapy Development forInfectious Disease Intervention 1149
SmellDysfunction:ABiomarkerforCOVID-19 1150
SARS-CoV-2 Seroconversion in Humans:A Detailed Protocol for a SerologicalAssay, Antigen Production, and TestSetup 1151
Research and Funding in the Time of COVID-19 1152
Turning sandstorms into pearls 1153
Drug repositioning: a brief overview 1154
The Utah Model: mental bandwidth and strategic risk generation in COVID-19 airway management 1155
 How we  deal  with  the  COVID-19  epidemic  in  an  Italian  pediatric  onco-hematology clinic located in a region at high density of cases 1156
Estimation of basic reproduction number for COVID-19 and the reasons for its differences Hadis Najafimehr1, Kosar Mohamed Ali2, Saeed Safari3, Mahmoud Yousefifard4*, ostafa Hosseini 1157
COVID-19: 2020 a year in turmoil 1158
The prospects fortheSARS-CoV-2 pandemic in Africa 1159
A Policy to Do Better Next Time: Lessons Learned from the Covid-19 Pandemic 1160
Built-in   RNA-mediated   Chaperone   (Chaperna)   for   Antigen   Folding Tailored to Immunized Hosts 1161
Care of Immunocompromised Patients with Head and Neck Cancer During the COVID-19 Pandemic: Two Challenging and Informative Clinical Cases 1162
How to avoid nosocomial spread during Tracheostomy for Covid-19 patients 1163
Endocrine Surgery in the Coronavirus Disease 2019 Pandemic 1164
Disproportionate impact of COVID-19 Pandemic on Head and Neck Cancer Survivors 1165
Head and neck virtual medicine in a pandemic era: lessons from COVID-19 1166
Management of the Difficult Airway in the COVID-19 Pandemic: An Illustrative Complex Head and Neck Case Scenario 1167
A Commentary on the Management of Total Laryngectomy PatientsDuring the COVID-19 Pandemic 1168
A Framework for Prioritizing Head and Neck Surgery during the COVID-19 Pandemic 1169
Failure in initial stage containment of global COVID-19 epicenters 1170
COVID-19: Recommended sampling sites at different stage of the disease 1171
Case fatality rate analysis of Italian COVID-19 outbreak 1172
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement 1173
Off-label UseofTocilizumab in Patients with SARS-CoV-2 Infection 1174
VIROLOGICAL AND CLINICAL CURE IN COVID-19 PATIENTS TREATED WITH HYDROXYCHLOROQUINE: A SYSTEMATIC REVIEW AND META-ANALYSIS 1175
High IL-6/IFN-γ ratio could be associated withsevere disease in COVID-19 patients 1176
The use of UV fluorescent powder for COVID-19 airway management simulationtraining 1177
The role of childrenin the transmission of mildSARS-CoV-2 infection 1178
Relationships   among   Lymphocyte   Subsets,   Cytokines,   and   the   Pulmonary   Inflammation   Index   in 10Coronavirus (COVID-19) Infected Patients 1179
Reactive lymphocytes in patients with Covid‐19 1180
Management of COVID-19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory 1181
Guide to Immunopharmacology: a database to boost immunologyeducation, research and therapy 1182
Non-cutaneous considerations of COVID19 for dermatology practices 1183
COVID-19and student nurses: a view from England 1184
Management of Infantile Hemangiomas during the COVID Pandemic 1185
How to Guarantee the Best of Care to Patients with CancerDuring the COVID-19 Epidemic: The Italian Experience 1186
CORRESPONDANCE Reflections and New Developments within the COVID-19 Pandemic  1187
REPLY(by Kevin Welch)to Zara Patel CORRESPONDENCE 1188
Telesupported procedures:when and how 1189
EMPLOYING DERMATOLOGISTS ON THE FRONTLINE AGAINST COVID-19: ALL HANDS ON DECK 1190
CORONAVIRUS-DAYS IN DERMATOLOGY 1191
Improving Communication About COVID-19 and Other Emerging Infectious Diseases 1192
Exaggerated information and COVID-19 outbreak 1193
Concerns  related  to  COVID-19  pandemic  among  patients  with  Inflammatory  Bowel  Disease, and its influence on patients management. 1194
On the alert for cytokine storm: Immunopathology in COVID-19 1195
Global guidance for surgical care during theCOVID-19 pandemic 1196
Moving biochemistry and molecular biology coursesonline in times of disruption: Recommended practicesand resources - a collaboration with the faculty communityand ASBMB 1197
Coronavirus and the hearts of doctors 1198
Coronavirus, Climate Change, and a Bit of Hope  1199
Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better 1200
Treatment with convalescent plasma for COVID-19 patientsin Wuhan, China 1201
Clinical characteristics of COVID-19: a meta-analysis 1202
Possibly critical role of wearing masks in general population in controllingCOVID-19 1203
Hyperglycemia, Hydroxychloroquine, and the COVID-19 Epidemic 1204
Concomitant neurological symptomsobserved in a patient diagnosed with coronavirus disease 2019 1205
Does COVID-19 Disprove the Obesity Paradox in ARDS
1206
The Impact of COVID-19 on Bariatric Surgery: Re-Defining Psychosocial Care 1207
The impact of COPD and smoking history onthe severity of Covid-19:A systemic review and meta-analysis 1208
Coinfection with COVID-19 and Coronavirus HKU1 –the critical need for repeat testing if clinically indicated 1209
Analysis of 92 deceased patients with COVID-19 1210
SARS-CoV-2: at the crossroad between aging and neurodegeneration  1211
COVID-19 VAGINAL DELIVERY – A CASE REPORT   1212
Letter to the Editor Re: Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures 1213
SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability 1214
The Neverending Shift: A feminist reflectiononliving and organisingacademic livesduring the Coronavirus pandemic 1215
Norming COVID-19: The Urgency of a Non-Humanist Holism 1216
SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor 1217
Viral exanthem in COVID-19, a clinical enigma with biological significance 1218
Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies 1219
A distinctive skin rash associated with Coronavirus Disease 2019
1220
All roads lead to coronavirus 1221
Amiodarone as a possible therapy for coronavirus infection 1222
The pandemic of coronavirus: tackling the latest plague 1223
2019 CORONAVIRUS: What are the implications for cardiology? 1224
Feline coronavirus-associated myocarditis in a domestic longhair cat 1225
Psychological assistance during the coronavirus disease 2019 outbreak in China 1226
Coronavirus Disease 2019 (COVID-19): Considerations for the Competitive Athlete 1227
Pediatric Characteristics of 2019 Novel Coronavirus: Review of Available Published Literature 1228
Visualising the expansion and spread of coronavirus disease 2019 by cartograms 1229
Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19) 1230
The outbreak of COVID-19 coronavirus and its impact on global mental health 1231
Structure of the SARS-Unique Domain C From the Bat Coronavirus HKU4 1232
Electrolyte Imbalances in Patients with Severe Coronavirus Disease 2019 (COVID-19) 1233
Effect of cat litters on feline coronavirus infection of cell culture and cats 1234
Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine 1235
Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) Pandemic 1236
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) 1237
Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice 1238
COVID-19 infodemic: More retweets for science-basedinformation on coronavirus than for false information 1239
Detection of feline coronavirus mutations in paraffin-embedded tissues in cats with feline infectious peritonitis and controls 1240
Distinct mutation in the feline coronavirus spike protein cleavage activation site in a cat with feline infectious peritonitis-associated meningoencephalomyelitis 1241
Feline coronavirus with and without spike gene mutations detected by real-time RT-PCRs in cats with feline infectious peritonitis 1242
Preliminary investigation on feline coronavirus presence in the reproductive tract of the tom cat as a potential route of viral transmission 1243
Does the direct renin inhibitor have a role to play in attenuating severity of the outbreak coronavirus disease 2019 (COVID-19)? 1244
Severe acute respiratory syndrome coronavirus 2 infection, angiotensin- converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers 1245
A dialogue between the editor-in-chief and a deputy editor of a cardiology journal during the coronavirus outbreak: Take-home messages from the Italian experience 1246
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study 1247
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease 1248
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province 1249
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model 1250
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study 1251
Pediatric Endoscopy in the Era of COVID-19: A NASPGHAN Position Paper 1252
Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19) 1253
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study 1254
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease 1255
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province 1256
Computed Tomography Manifestations of 5 Cases of the Novel Coronavirus Disease 2019 (COVID-19) Pneumonia From Patients Outside Wuhan 1257
High-Resolution Computed Tomography Manifestations of 5 Pediatric Patients With 2019 Novel Coronavirus 1258
Mental Health Care Providers Dealing With Coronavirus Disease 2019 (COVID-19): What Is the Definition of a Case, How Is That Changing, and What Kinds of Tests Are Available? 1259
Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients with ST Segment Elevation Myocardial Infarction 1260
Rehospitalization of a Recovered Coronavirus Disease 19 (COVID-19) Child With Positive Nucleic Acid Detection 1261
Coronavirus Infections in Children Including COVID-19 An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children 1262
Imaging features and mechanisms of novel coronavirus pneumonia (COVID-19) Study Protocol Clinical Trial (SPIRIT Compliant) 1263
First Case of 2019 Novel Coronavirus in the United States 1264
A Novel Coronavirus from Patients with Pneumonia in China, 2019 1265
Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients A 2-year prospective cohort study 1266
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) 1267
The persistence and clearance of viral RNA in 2019 novel coronavirus disease survivors 1268
Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial 1269
Perioperative Management of Patients Infected with the Novel Coronavirus 1270
The Surgeon’s Role During the Coronavirus Pandemic 1271
Coronaviruses and SARS-CoV-2: A Brief Overview 1272
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China 1273
Orthopaedic Surgical Selection and Inpatient Paradigms During the COVID-19 Pandemic 1274
Coronavirus Disease 2019 (COVID-19) and Pregnancy Responding to a Rapidly Evolving Situation 1275
Obstetricians on the Coronavirus Disease 2019 (COVID-19) Front Lines and the Confusing World of Personal Protective Equipment 1276
Clinical Characteristics of Coronavirus Disease 2019 in China 1277
Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature 1278
Protected Code Stroke Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic 1279
Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features 1280
Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report 1281
Coronavirus Disease 2019: In-Home Isolation Room Construction 1282
A Multidisciplinary Team Approach for Triage of Elective Cancer Surgery at the Massachusetts General Hospital During the Novel Coronavirus COVID-19 Outbreak 1283
The Role of the American Heart Association in the Global COVID-19 Pandemic 1284
SARS-CoV-2 Infection among Travelers Returning from Wuhan, China 1285
Managing the Stress of the Covid-19 Pandemic 1286
COVID19 –Nuclear Medicine Departments, be prepared! 1287
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China 1288
The Role of Viral Coinfection in Bronchiolitis Treated With High-Flow Nasal Cannula at PediatricEmergency Department During 2 Consecutive Seasons An Observational Study 1289
COVID-19 Continues to Spread 1290
Rehabilitation following critical illness in people with COVID-19 infection 1291
coronavirus-19 (COVID-19) 1292
Incidental CT Findings Suspicious for Covid-19 Associated Pneumonia on Nuclear Medicine Exams: Recognition and Management Plan 1293
FECAL-ORAL TRANSMISSION OF SARS-COV-2 IN CHILDREN 1294
Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC) 1295
Transmission of respiratory tract infections at mass gathering events 1296
Oncologist Urges COVID-19 “Castrated” Live Vaccine Initiative 1297
coronavirus disease 2019 (COVID-19) 1298
Managing Resident Workforce and Education During the COVID-19 Pandemic 1299
Managing Resident Workforce and Education During the COVID-19 Pandemic 1300
Diseases of the Colon & Rectum Publish Ahead of Print 1301
Deep Learning Localization of Pneumonia 2019 Coronavirus (COVID-19) Outbreak 1302
Coinfection of Influenza Virus and Severe Acute RespiratorySyndrome Coronavirus 2(SARS-COV-2) 1303
Use of HandheldTransceiver for HospitalHealthcare Workers-Caregiver Communication During the Coronavirusdisease 2019 (COVID-19)Outbreak in PediatricEmergency Department 1304
The explosive epidemic outbreak of novelcoronavirus disease 2019 (COVID-19) and thepersistent threat of respiratory tract infectiousdiseases to global health security 1305
Brace for Chloroquine PoisoningsBecause of the Coronavirus Pandemic 1306
Impact of Coronavirus Disease 2019 (COVID-19)Outbreak on ST-Segment–Elevation MyocardialInfarction Care in Hong Kong, China 1307
Take Precautions 1308
Coronavirus disease 2019 (COVID-19) 1309
Renin-Angiotensin System Blockers andthe COVID-19 Pandemic 1310